Cross-Species Transcriptional Characterization of Retinorecipient Neuronal Populations
Award Notice Posted
- Solicitation number
- 75N95024Q01789
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Cs27 LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95024P00237 Federal contract award
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Springboro, Ohio, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute on Drug Abuse (NIDA) awarded a Firm-Fixed-Price contract to CS27, LLC to acquire Cross-Species Transcriptional Characterization of Retinorecipient Neuronal Populations. The contract has a base period of performance with the potential for option periods, resulting in a total performance period of three years. The initial award amount is $49,500.00, with a total potential award value of $148,500.00.
Notice text
NOTICE OF AWARD. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS.
On April 12, 2024; in response to the requirements of Solicitation 75N95024Q01789, the National Institute on Drug Abuse (NIDA) awarded a Purchase Order No. 75N95024P00237 to CS27, LLC To acquire Cross-Species
Transcriptional Characterization of Retinorecipient Neuronal Populations. NIDA anticipates the use of Option Periods with an ultimate Period of Performance of three (3) years. An award shall be made on a Firm-Fixed-Price basis. Funding in the amount of $49,500.00 shall be obligated to fully fund the Base Period of this award.
Awarded contract 75N95024P00237 to CS27 LLC for 148500.00 on 2024-04-12.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Cross-Species Transcriptional Characterization of Retinorecipient Neuronal Populations | Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity